Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial

MGM Derks; EJ Blok; Caroline Seynaeve; JWR Nortier; EMK Kranenbarg; GJ Liefers; H Putter; JR Kroep; D Rea; A Hasenburg; C Markopoulos; R Paridaens; JBE Smeets; LY Dirix; CJH van de Velde

doi:10.1016/s1470-2045(17)30419-9

Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial

MGM Derks
, EJ Blok
, Caroline Seynaeve
, JWR Nortier
, EMK Kranenbarg
, GJ Liefers
, H Putter
, JR Kroep
, D Rea
, A Hasenburg
, C Markopoulos
, R Paridaens
, JBE Smeets
, LY Dirix
, CJH van de Velde

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

52 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1211-1220
Number of pages	10
Journal	Lancet Oncology
Volume	18
Issue number	9
DOIs	https://doi.org/10.1016/s1470-2045(17)30419-9
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-86-01

Access to Document

10.1016/s1470-2045(17)30419-9

http://hdl.handle.net/1765/108177

Cite this

Derks, MGM., Blok, EJ., Seynaeve, C., Nortier, JWR., Kranenbarg, EMK., Liefers, GJ., Putter, H., Kroep, JR., Rea, D., Hasenburg, A., Markopoulos, C., Paridaens, R., Smeets, JBE., Dirix, LY., & van de Velde, CJH. (2017). Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 18(9), 1211-1220. https://doi.org/10.1016/s1470-2045(17)30419-9

@article{e32f9ff426fa487f9ef4346413a71418,

title = "Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial",

author = "MGM Derks and EJ Blok and Caroline Seynaeve and JWR Nortier and EMK Kranenbarg and GJ Liefers and H Putter and JR Kroep and D Rea and A Hasenburg and C Markopoulos and R Paridaens and JBE Smeets and LY Dirix and \{van de Velde\}, CJH",

year = "2017",

doi = "10.1016/s1470-2045(17)30419-9",

language = "Undefined/Unknown",

volume = "18",

pages = "1211--1220",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "9",

}

Derks, MGM, Blok, EJ, Seynaeve, C, Nortier, JWR, Kranenbarg, EMK, Liefers, GJ, Putter, H, Kroep, JR, Rea, D, Hasenburg, A, Markopoulos, C, Paridaens, R, Smeets, JBE, Dirix, LY & van de Velde, CJH 2017, 'Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial', Lancet Oncology, vol. 18, no. 9, pp. 1211-1220. https://doi.org/10.1016/s1470-2045(17)30419-9

TY - JOUR

T1 - Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial

AU - Derks, MGM

AU - Blok, EJ

AU - Seynaeve, Caroline

AU - Nortier, JWR

AU - Kranenbarg, EMK

AU - Liefers, GJ

AU - Putter, H

AU - Kroep, JR

AU - Rea, D

AU - Hasenburg, A

AU - Markopoulos, C

AU - Paridaens, R

AU - Smeets, JBE

AU - Dirix, LY

AU - van de Velde, CJH

PY - 2017

Y1 - 2017

U2 - 10.1016/s1470-2045(17)30419-9

DO - 10.1016/s1470-2045(17)30419-9

M3 - Article

SN - 1470-2045

VL - 18

SP - 1211

EP - 1220

JO - Lancet Oncology

JF - Lancet Oncology

IS - 9

ER -